These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Bacterial flora in irritable bowel syndrome: role in pathophysiology, implications for management. Quigley EM J Dig Dis; 2007 Feb; 8(1):2-7. PubMed ID: 17261128 [TBL] [Abstract][Full Text] [Related]
6. Long-Term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Madrid AM; Hurtado C; Venegas M; Cumsille F; Defilippi C Am J Gastroenterol; 2001 Apr; 96(4):1251-5. PubMed ID: 11316178 [TBL] [Abstract][Full Text] [Related]
7. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517 [TBL] [Abstract][Full Text] [Related]
8. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy. Bongaerts G; Severijnen R; Timmerman H Med Hypotheses; 2005; 64(1):64-8. PubMed ID: 15533613 [TBL] [Abstract][Full Text] [Related]
10. Probiotics, prebiotics, and synbiotics. de Vrese M; Schrezenmeir J Adv Biochem Eng Biotechnol; 2008; 111():1-66. PubMed ID: 18461293 [TBL] [Abstract][Full Text] [Related]
11. Small intestinal bacterial overgrowth: diagnosis and treatment. Gasbarrini A; Lauritano EC; Gabrielli M; Scarpellini E; Lupascu A; Ojetti V; Gasbarrini G Dig Dis; 2007; 25(3):237-40. PubMed ID: 17827947 [TBL] [Abstract][Full Text] [Related]
12. ACG Clinical Guideline: Small Intestinal Bacterial Overgrowth. Pimentel M; Saad RJ; Long MD; Rao SSC Am J Gastroenterol; 2020 Feb; 115(2):165-178. PubMed ID: 32023228 [TBL] [Abstract][Full Text] [Related]
13. Protein-losing enteropathy in the human and experimental rat blind-loop syndrome. King CE; Toskes PP Gastroenterology; 1981 Mar; 80(3):504-9. PubMed ID: 7450442 [TBL] [Abstract][Full Text] [Related]
14. Bacteria: a new player in gastrointestinal motility disorders--infections, bacterial overgrowth, and probiotics. Quigley EM Gastroenterol Clin North Am; 2007 Sep; 36(3):735-48, xi. PubMed ID: 17950446 [TBL] [Abstract][Full Text] [Related]
15. Bacterial translocation from the gastrointestinal tract. Berg RD J Med; 1992; 23(3-4):217-44. PubMed ID: 1479301 [TBL] [Abstract][Full Text] [Related]
16. The concept of small intestinal bacterial overgrowth in relation to functional gastrointestinal disorders. Gibson PR; Barrett JS Nutrition; 2010; 26(11-12):1038-43. PubMed ID: 20418060 [TBL] [Abstract][Full Text] [Related]
17. Management of Small Intestinal Bacterial Overgrowth in Adult Patients. Rasmussen J; Duriancik DM Gastroenterol Nurs; 2019; 42(3):269-276. PubMed ID: 31145251 [TBL] [Abstract][Full Text] [Related]
18. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation. Rosania R; Giorgio F; Principi M; Amoruso A; Monno R; Di Leo A; Ierardi E Curr Clin Pharmacol; 2013 May; 8(2):169-72. PubMed ID: 23244247 [TBL] [Abstract][Full Text] [Related]
19. Bacterial overgrowth as a cause of irritable bowel syndrome. Riordan SM; Kim R Curr Opin Gastroenterol; 2006 Nov; 22(6):669-73. PubMed ID: 17053447 [TBL] [Abstract][Full Text] [Related]
20. The pathogenesis of gastrointestinal bacterial overgrowth. Husebye E Chemotherapy; 2005; 51 Suppl 1():1-22. PubMed ID: 15855746 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]